FAN J H , ZHANG Y Q , SHI S S , et al . A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in China [J ] . Oncotarget , 2017 , 8 ( 42 ): 71699 - 71708 . DOI: 10.18632/oncotarget.17599 http://doi.org/10.18632/oncotarget.17599 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.17599 https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.17599

WU W M , CHEN J , BAI C M , et al . The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020) [J ] . Chin J Surg , 2021 , 59 ( 6 ): 401 - 421 .

CIVES M , STROSBERG J R . Gastroenteropancreatic neuroendocrine tumors [J ] . CA Cancer J Clin , 2018 , 68 ( 6 ): 471 - 487 . DOI: 10.3322/caac.21493 http://doi.org/10.3322/caac.21493 http://doi.wiley.com/10.3322/caac.21493 http://doi.wiley.com/10.3322/caac.21493

DASARI A , SHEN C , HALPERIN D , et al . Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States [J ] . JAMA Oncol , 2017 , 3 ( 10 ): 1335 - 1342 . DOI: 10.1001/jamaoncol.2017.0589 http://doi.org/10.1001/jamaoncol.2017.0589

SCARPA A , CHANG D K , NONES K , et al . Whole-genome landscape of pancreatic neuroendocrine tumours [J ] . Nature , 2017 , 543 ( 7643 ): 65 - 71 . DOI: 10.1038/nature21063 http://doi.org/10.1038/nature21063 http://www.nature.com/articles/nature21063 http://www.nature.com/articles/nature21063

刘大为 . 一个值得深思的问题:重症治疗是病情导向抑或治疗目标导向 [J ] . 中华内科杂志 , 2022 , 61 ( 6 ): 607 - 610 .

LIU D W . Target directed therapy in critical patients, to be or not to be [J ] . Chin J Intern Med , 2022 , 61 ( 6 ): 607 - 610 .

中国抗癌协会神经内分泌肿瘤专业委员会 . 中国抗癌协会神经内分泌肿瘤诊治指南(2022年版) [J ] . 中国癌症杂志 , 2022 , 32 ( 6 ): 545 - 579 .

Society of Neuroendocrine Neoplasm of China Anti-Cancer Association . China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasm (2022 edition) [J ] . CHINA ONCOLOGY , 2022 , 32 ( 6 ): 545 - 579 . DOI: 10.19401/j.cnki.1007-3639.2022.06.010 http://doi.org/10.19401/j.cnki.1007-3639.2022.06.010

KULKARNI R , KABIR I , HODSON J , et al . Impact of the extent of resection of neuroendocrine tumor liver metastases on survival: a systematic review and meta-analysis [J ] . Ann Hepatobiliary Pancreat Surg , 2022 , 26 ( 1 ): 31 - 39 . DOI: 10.14701/ahbps.21-101 http://doi.org/10.14701/ahbps.21-101 http://www.ahbps.org/journal/view.html?doi=10.14701/ahbps.21-101 http://www.ahbps.org/journal/view.html?doi=10.14701/ahbps.21-101

MEROLA E , FALCONI M , RINKE A , et al . Radical intended surgery for highly selected stage Ⅳ neuroendocrine neoplasms G3 [J ] . Am J Surg , 2020 , 220 ( 2 ): 284 - 289 . DOI: 10.1016/j.amjsurg.2020.03.009 http://doi.org/10.1016/j.amjsurg.2020.03.009 https://linkinghub.elsevier.com/retrieve/pii/S0002961020301513 https://linkinghub.elsevier.com/retrieve/pii/S0002961020301513

MEROLA E , RINKE A , PARTELLI S , et al . Surgery with radical intent: is there an indication for G3 neuroendocrine neoplasms? [J ] . Ann Surg Oncol , 2020 , 27 ( 5 ): 1348 - 1355 . DOI: 10.1245/s10434-019-08049-5 http://doi.org/10.1245/s10434-019-08049-5

LEWIS A , RAOOF M , ITUARTE P H G , et al . Resection of the primary gastrointestinal neuroendocrine tumor improves survival with or without liver treatment [J ] . Ann Surg , 2019 , 270 ( 6 ): 1131 - 1137 . DOI: 10.1097/SLA.0000000000002809 http://doi.org/10.1097/SLA.0000000000002809

ZHANG X F , XUE F , DONG D H , et al . New nodal staging for primary pancreatic neuroendocrine tumors: a multi-institutional and national data analysis [J ] . Ann Surg , 2021 , 274 ( 1 ): e28 -e35. DOI: 10.1097/SLA.0000000000003478 http://doi.org/10.1097/SLA.0000000000003478 https://journals.lww.com/10.1097/SLA.0000000000003478 https://journals.lww.com/10.1097/SLA.0000000000003478

RINDI G , KLIMSTRA D S , ABEDI-ARDEKANI B , et al . A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal [J ] . Mod Pathol , 2018 , 31 ( 12 ): 1770 - 1786 . DOI: 10.1038/s41379-018-0110-y http://doi.org/10.1038/s41379-018-0110-y https://doi.org/10.1038/s41379-018-0110-y https://doi.org/10.1038/s41379-018-0110-y

LUO G P , JAVED A , STROSBERG J R , et al . Modified staging classification for pancreatic neuroendocrine tumors on the basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems [J ] . J Clin Oncol , 2017 , 35 ( 3 ): 274 - 280 . DOI: 10.1200/JCO.2016.67.8193 http://doi.org/10.1200/JCO.2016.67.8193

ZHANG X F , XUE F , WU Z , et al . Development and validation of a modified eighth AJCC staging system for primary pancreatic neuroendocrine tumors [J ] . Ann Surg , 2022 , 275 ( 6 ): e773 -e780. DOI: 10.1097/SLA.0000000000004039 http://doi.org/10.1097/SLA.0000000000004039 https://journals.lww.com/10.1097/SLA.0000000000004039 https://journals.lww.com/10.1097/SLA.0000000000004039

WANG M , DING D , QIN T T , et al . New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification[ [J ] . Cancer Lett , 2021 , 518 : 207 - 213 . DOI: 10.1016/j.canlet.2021.07.018 http://doi.org/10.1016/j.canlet.2021.07.018 https://linkinghub.elsevier.com/retrieve/pii/S0304383521003463 https://linkinghub.elsevier.com/retrieve/pii/S0304383521003463

YAN J , YU S N , JIA C W , et al . Molecular subtyping in pancreatic neuroendocrine neoplasms: new insights into clinical, pathological unmet needs and challenges [J ] . Biochim Biophys Acta Rev Cancer , 2020 , 1874 ( 1 ): 188367.

KAWASAKI K , TOSHIMITSU K , MATANO M , et al . An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping [J ] . Cell , 2020 , 183 ( 5 ): 1420 - 1435 .e21. DOI: 10.1016/j.cell.2020.10.023 http://doi.org/10.1016/j.cell.2020.10.023

SALLINEN V , HAGLUND C , SEPPÄNEN H . Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: do size and symptoms matter? [J ] . Surgery , 2015 , 158 ( 6 ): 1556 - 1563 . DOI: 10.1016/j.surg.2015.04.035 http://doi.org/10.1016/j.surg.2015.04.035 https://linkinghub.elsevier.com/retrieve/pii/S0039606015003657 https://linkinghub.elsevier.com/retrieve/pii/S0039606015003657

PAIK W H , LEE H S , LEE K J , et al . Malignant potential of small pancreatic neuroendocrine neoplasm and its risk factors: a multicenter nationwide study [J ] . Pancreatology , 2021 , 21 ( 1 ): 208 - 214 . DOI: 10.1016/j.pan.2020.11.016 http://doi.org/10.1016/j.pan.2020.11.016

MIRKIN K A , HOLLENBEAK C S , WONG J . Impact of chromogranin A, differentiation, and mitoses in nonfunctional pancreatic neuroendocrine tumors ≤ 2 cm [J ] . J Surg Res , 2017 , 211 : 206 - 214 . DOI: 10.1016/j.jss.2016.12.033 http://doi.org/10.1016/j.jss.2016.12.033 https://linkinghub.elsevier.com/retrieve/pii/S0022480416305832 https://linkinghub.elsevier.com/retrieve/pii/S0022480416305832

HAN I W , PARK J , PARK E Y , et al . Fate of surgical patients with small nonfunctioning pancreatic neuroendocrine tumors: an international study using multi-institutional registries [J ] . Cancers , 2022 , 14 ( 4 ): 1038 . DOI: 10.3390/cancers14041038 http://doi.org/10.3390/cancers14041038 https://www.mdpi.com/2072-6694/14/4/1038 https://www.mdpi.com/2072-6694/14/4/1038

DE ROBERTIS R , MARIS B , CARDOBI N , et al . Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? [J ] . Eur Radiol , 2018 , 28 ( 6 ): 2582 - 2591 . DOI: 10.1007/s00330-017-5236-7 http://doi.org/10.1007/s00330-017-5236-7

PAIELLA S , LANDONI L , TEBALDI S , et al . Dual-tracer( 68 Ga-DOTATOC and 18 F-FDG-)-PET/CT scan and G1-G2 nonfunctioning pancreatic neuroendocrine tumors: a single-center retrospective evaluation of 124 nonmetastatic resected cases [J ] . Neuroendocrinology , 2022 , 112 ( 2 ): 143 - 152 . DOI: 10.1159/000514809 http://doi.org/10.1159/000514809 https://www.karger.com/Article/FullText/514809 https://www.karger.com/Article/FullText/514809

HACKENG W M , BROSENS L A A , KIM J Y , et al . Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size [J ] . Gut , 2022 , 71 ( 5 ): 961 - 973 . DOI: 10.1136/gutjnl-2020-322595 http://doi.org/10.1136/gutjnl-2020-322595 https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2020-322595 https://gut.bmj.com/lookup/doi/10.1136/gutjnl-2020-322595

PEA A , YU J , MARCHIONNI L , et al . Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases [J ] . Ann Surg , 2020 , 271 ( 3 ): 566 - 573 . DOI: 10.1097/SLA.0000000000003022 http://doi.org/10.1097/SLA.0000000000003022

QUEVEDO R , SPREAFICO A , BRUCE J , et al . Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumor [J ] . Genome Med , 2020 , 12 ( 1 ): 38 . DOI: 10.1186/s13073-020-00730-9 http://doi.org/10.1186/s13073-020-00730-9

TANG X , SHAO Y , YI X , et al . Metastatic timing and genetic heterogeneity in the evolution of a pancreatic neuroendocrine tumor [J ] . Am J Gastroenterol , 2021 , 116 ( 4 ): 844 - 847 .

RINDI G , METE O , UCCELLA S , et al . Overview of the 2022 WHO classification of neuroendocrine neoplasms [J ] . Endocr Pathol , 2022 , 33 ( 1 ): 115 - 154 . DOI: 10.1007/s12022-022-09708-2 http://doi.org/10.1007/s12022-022-09708-2

TITAN A L , NORTON J A , FISHER A T , et al . Evaluation of outcomes following surgery for locally advanced pancreatic neuroendocrine tumors [J ] . JAMA Netw Open , 2020 , 3 ( 11 ): e2024318.

GAO S Z , SHI X H , MA H Y , et al . The effect of using long-acting octreotide as adjuvant therapy for patients with grade 2 pancreatic neuroendocrine tumors after radical resection [J ] . J Pancreatol , 2020 , 3 ( 4 ): 167 - 172 .

WANG W Q , ZHANG W H , GAO H L , et al . A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors [J ] . J Gastroenterol , 2021 , 56 ( 4 ): 395 - 405 . DOI: 10.1007/s00535-021-01777-0 http://doi.org/10.1007/s00535-021-01777-0 https://doi.org/10.1007/s00535-021-01777-0 https://doi.org/10.1007/s00535-021-01777-0

PULVIRENTI A , JAVED A A , LANDONI L , et al . Multi-institutional development and external validation of a nomogram to predict recurrence after curative resection of pancreatic neuroendocrine tumors [J ] . Ann Surg , 2021 , 274 ( 6 ): 1051 - 1057 . DOI: 10.1097/SLA.0000000000003579 http://doi.org/10.1097/SLA.0000000000003579 https://journals.lww.com/10.1097/SLA.0000000000003579 https://journals.lww.com/10.1097/SLA.0000000000003579

CHAN C S , LADDHA S V , LEWIS P W , et al . ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup [J ] . Nat Commun , 2018 , 9 ( 1 ): 4158 . DOI: 10.1038/s41467-018-06498-2 http://doi.org/10.1038/s41467-018-06498-2

LAWRENCE B , BLENKIRON C , PARKER K , et al . Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer [J ] . NPJ Genom Med , 2018 , 3 : 18 . DOI: 10.1038/s41525-018-0058-3 http://doi.org/10.1038/s41525-018-0058-3

HONG X F , QIAO S T , LI F Q , et al . Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system [J ] . Gut , 2020 , 69 ( 5 ): 877 - 887 . DOI: 10.1136/gutjnl-2018-317233 http://doi.org/10.1136/gutjnl-2018-317233

SADANANDAM A , WULLSCHLEGER S , LYSSIOTIS C A , et al . A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics [J ] . Cancer Discov , 2015 , 5 ( 12 ): 1296 - 1313 . DOI: 10.1158/2159-8290.CD-15-0068 http://doi.org/10.1158/2159-8290.CD-15-0068

YAO J , GARG A , CHEN D , et al . Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials [J ] . Endocr Relat Cancer , 2019 , 26 ( 4 ): 391 - 403 . DOI: 10.1530/ERC-18-0332 http://doi.org/10.1530/ERC-18-0332 https://erc.bioscientifica.com/view/journals/erc/26/4/ERC-18-0332.xml https://erc.bioscientifica.com/view/journals/erc/26/4/ERC-18-0332.xml

WEI M Y , XU J , HUA J , et al . From the immune profile to the immunoscore: signatures for improving postsurgical prognostic prediction of pancreatic neuroendocrine tumors [J ] . Front Immunol , 2021 , 12 : 654660.

KIDD M , MODLIN I , ÖBERG K . Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms [J ] . Nat Rev Clin Oncol , 2016 , 13 ( 11 ): 691 - 705 . DOI: 10.1038/nrclinonc.2016.85 http://doi.org/10.1038/nrclinonc.2016.85

YOUNG K , STARLING N , SADANANDAM A . The molecular biology of pancreatic neuroendocrine neoplasms: challenges and translational opportunities [J ] . Semin Cancer Biol , 2020 , 61 : 132 - 138 . DOI: S1044-579X(19)30291-3 http://doi.org/S1044-579X(19)30291-3

GAY-CHEVALLIER S , DE MESTIER L , PERINEL J , et al . Management and prognosis of localized duodenal neuroendocrine neoplasms [J ] . Neuroendocrinology , 2021 , 111 ( 8 ): 718 - 727 . DOI: 10.1159/000508102 http://doi.org/10.1159/000508102 https://www.karger.com/Article/FullText/508102 https://www.karger.com/Article/FullText/508102

WANG R , MOHAPATRA S , JOVANI M , et al . Risk factors for lymph node metastasis and survival of patients with nonampullary duodenal carcinoid tumors treated with endoscopic therapy versus surgical resection: analysis of the Surveillance, Epidemiology, and End Results program [J ] . Gastrointest Endosc , 2021 , 93 ( 6 ): 1384 - 1392 . DOI: 10.1016/j.gie.2020.12.012 http://doi.org/10.1016/j.gie.2020.12.012

RIMBAŞ M , HORUMBĂ M , RIZZATTI G , et al . Interventional endoscopic ultrasound for pancreatic neuroendocrine neoplasms [J ] . Dig Endosc , 2020 , 32 ( 7 ): 1031 - 1041 . DOI: 10.1111/den.13635 http://doi.org/10.1111/den.13635 https://onlinelibrary.wiley.com/doi/10.1111/den.13635 https://onlinelibrary.wiley.com/doi/10.1111/den.13635

MELITA G , PALLIO S , TORTORA A , et al . Diagnostic and interventional role of endoscopic ultrasonography for the management of pancreatic neuroendocrine neoplasms [J ] . J Clin Med , 2021 , 10 ( 12 ): 2638 . DOI: 10.3390/jcm10122638 http://doi.org/10.3390/jcm10122638 https://www.mdpi.com/2077-0383/10/12/2638 https://www.mdpi.com/2077-0383/10/12/2638

WANG M , PENG B , LIU J H , et al . Practice patterns and perioperative outcomes of laparoscopic pancreaticoduodenectomy in China: a retrospective multicenter analysis of 1029 patients [J ] . Ann Surg , 2021 , 273 ( 1 ): 145 - 153 . DOI: 10.1097/SLA.0000000000003190 http://doi.org/10.1097/SLA.0000000000003190 https://journals.lww.com/10.1097/SLA.0000000000003190 https://journals.lww.com/10.1097/SLA.0000000000003190

WANG M , LI D W , CHEN R F , et al . Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial [J ] . Lancet Gastroenterol Hepatol , 2021 , 6 ( 6 ): 438 - 447 . DOI: 10.1016/S2468-1253(21)00054-6 http://doi.org/10.1016/S2468-1253(21)00054-6 https://linkinghub.elsevier.com/retrieve/pii/S2468125321000546 https://linkinghub.elsevier.com/retrieve/pii/S2468125321000546

TAMBURRINO D , PARTELLI S , RENZI C , et al . Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs) [J ] . Expert Rev Gastroenterol Hepatol , 2017 , 11 ( 1 ): 65 - 73 . DOI: 10.1080/17474124.2017.1253473 http://doi.org/10.1080/17474124.2017.1253473 https://www.tandfonline.com/doi/full/10.1080/17474124.2017.1253473 https://www.tandfonline.com/doi/full/10.1080/17474124.2017.1253473

ZHANG H , LAN X , PENG B , et al . Is total laparoscopic pancreaticoduodenectomy superior to open procedure? A meta-analysis [J ] . World J Gastroenterol , 2019 , 25 ( 37 ): 5711 - 5731 . DOI: 10.3748/wjg.v25.i37.5711 http://doi.org/10.3748/wjg.v25.i37.5711 https://www.wjgnet.com/1007-9327/full/v25/i37/5711.htm https://www.wjgnet.com/1007-9327/full/v25/i37/5711.htm

GIULIANI T , DE PASTENA M , PAIELLA S , et al . Pancreatic enucleation patients share the same quality of life as the general population at long-term follow-up: a propensity-score matched analysis [J ] . Ann Surg , 2021 . Online ahead of print.

HUANG J , YADAV D K , XIONG C J , et al . Laparoscopic spleen-preserving distal pancreatectomy (LSPDP) versus open spleen-preserving distal pancreatectomy (OSPDP): a comparative study [J ] . Can J Gastroenterol Hepatol , 2019 , 2019 : 9367868.

LI A Y , VISSER B C , DUA M M . Surgical indications and outcomes of resection for pancreatic neuroendocrine tumors with vascular involvement [J ] . Cancers , 2022 , 14 ( 9 ): 2312 . DOI: 10.3390/cancers14092312 http://doi.org/10.3390/cancers14092312 https://www.mdpi.com/2072-6694/14/9/2312 https://www.mdpi.com/2072-6694/14/9/2312

WANG X Z , CHUNG W Y , CORREA E , et al . The integration of artificial intelligence models to augment imaging modalities in pancreatic cancer [J ] . J Pancreatol , 2020 , 3 ( 4 ): 173 - 180 .

BARI H , WADHWANI S , DASARI B V M . Role of artificial intelligence in hepatobiliary and pancreatic surgery [J ] . World J Gastrointest Surg , 2021 , 13 ( 1 ): 7 - 18 . DOI: 10.4240/wjgs.v13.i1.7 http://doi.org/10.4240/wjgs.v13.i1.7

HERNANDEZ VARGAS S , KOSSATZ S , VOSS J , et al . Specific targeting of somatostatin receptor subtype-2 for fluorescence-guided surgery [J ] . Clin Cancer Res , 2019 , 25 ( 14 ): 4332 - 4342 . DOI: 10.1158/1078-0432.CCR-18-3312 http://doi.org/10.1158/1078-0432.CCR-18-3312

LAUWERENDS L J , VAN DRIEL P B A A , BAATENBURG DE JONG R J , et al . Real-time fluorescence imaging in intraoperative decision making for cancer surgery [J ] . Lancet Oncol , 2021 , 22 ( 5 ): e186 -e195. DOI: 10.1016/S1470-2045(20)30600-8 http://doi.org/10.1016/S1470-2045(20)30600-8 https://linkinghub.elsevier.com/retrieve/pii/S1470204520306008 https://linkinghub.elsevier.com/retrieve/pii/S1470204520306008

FRILLING A , MODLIN I M , KIDD M , et al . Recommendations for management of patients with neuroendocrine liver metastases [J ] . Lancet Oncol , 2014 , 15 ( 1 ): e8 -e21. DOI: 10.1016/S1470-2045(13)70362-0 http://doi.org/10.1016/S1470-2045(13)70362-0 https://linkinghub.elsevier.com/retrieve/pii/S1470204513703620 https://linkinghub.elsevier.com/retrieve/pii/S1470204513703620

KAEMMERER D , TWRZNIK M , KULKARNI H R , et al . Prior resection of the primary tumor prolongs survival after peptide receptor radionuclide therapy of advanced neuroendocrine neoplasms [J ] . Ann Surg , 2021 , 274 ( 1 ): e45 -e53. DOI: 10.1097/SLA.0000000000003237 http://doi.org/10.1097/SLA.0000000000003237

SPOLVERATO G , BAGANTE F , ALDRIGHETTI L , et al . Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: an international multi-institutional analysis [J ] . J Surg Oncol , 2017 , 116 ( 3 ): 298 - 306 . DOI: 10.1002/jso.24670 http://doi.org/10.1002/jso.24670

SQUIRES M H , WORTH P J , KONDA B , et al . Neoadjuvant capecitabine/temozolomide for locally advanced or metastatic pancreatic neuroendocrine tumors [J ] . Pancreas , 2020 , 49 ( 3 ): 355 - 360 . DOI: 10.1097/MPA.0000000000001500 http://doi.org/10.1097/MPA.0000000000001500 https://journals.lww.com/10.1097/MPA.0000000000001500 https://journals.lww.com/10.1097/MPA.0000000000001500

MURASE Y , KUDO A , AKAHOSHI K , et al . Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms [J ] . Ann Gastroenterol Surg , 2021 , 5 ( 5 ): 692 - 700 . DOI: 10.1002/ags3.12458 http://doi.org/10.1002/ags3.12458

HIBI T , RELA M , EASON J D , et al . Liver transplantation for colorectal and neuroendocrine liver metastases and hepatoblastoma. Working group report from the ILTS transplant oncology consensus conference [J ] . Transplantation , 2020 , 104 ( 6 ): 1131 - 1135 . DOI: 10.1097/TP.0000000000003118 http://doi.org/10.1097/TP.0000000000003118

MORIS D , TSILIMIGRAS D I , NTANASIS-STATHOPOULOS I , et al . Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review [J ] . Surgery , 2017 , 162 ( 3 ): 525 - 536 . DOI: 10.1016/j.surg.2017.05.006 http://doi.org/10.1016/j.surg.2017.05.006 https://linkinghub.elsevier.com/retrieve/pii/S0039606017303240 https://linkinghub.elsevier.com/retrieve/pii/S0039606017303240

MAZZAFERRO V , SPOSITO C , COPPA J , et al . The long-term benefit of liver transplantation for hepatic metastases from neuroendocrine tumors [J ] . Am J Transplant , 2016 , 16 ( 10 ): 2892 - 2902 . DOI: 10.1111/ajt.13831 http://doi.org/10.1111/ajt.13831